US PTAB Patent Cases
8,574 decisions indexed
Page 226 of 286 · 8,574 total
Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.
Merck Sharp & Dohme LLC successfully challenged Halozyme, Inc.'s patent on enablement and obviousness grounds in a PTAB decision. The Board found that the patent documents supported a broad definition of modified PH20 polypeptides, while noting the petitioner had established a likelihood of prevailing on enablement but failed to prove obviousness.
Micron Technology, Inc. et al. v.Yangtze Memory Technologies Company, Ltd.
Micron Technology successfully instituted PGR against Yangtze Memory Technologies regarding a patent on 3D memory structures. The Board found that the petitioner sufficiently demonstrated obviousness over prior art references Kim and Lee for multiple claims. This moves the dispute into trial phase, raising significant stakes in semiconductor technology licensing.
Kubota North America Corporation et al. v.Vermeer Manufacturing Company
Kubota North America Corporation successfully petitioned PGR against Vermeer Manufacturing Company's patent for agricultural machinery, leading to institution on all 11 challenged claims. The Board found sufficient evidence of anticipation and obviousness based on prior art references like KR996.
Therabody, Inc. v.Hyperice IP Subco, LLC et al.
Therabody successfully challenged Hyperice's patent claims in a PTAB proceeding focused on massaging devices. The Board found likelihood of unpatentability based on obviousness and statutory deficiencies, particularly regarding the combination of prior art references.
ITM Isotope Technologies Munich SE v.The Johns Hopkins University et al.
ITM Isotope Technologies Munich SE challenged The Johns Hopkins University's claims regarding FAP-α targeting moieties based on obviousness and patentability issues (103/112). The Board instituted the PGR, finding that the claims face significant challenges related to enablement and indefiniteness.
Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.
The PTAB instituted the PGR petition challenging Halozyme's patent covering modified PH20 polypeptides. The Board found that the claims were not sufficiently supported by the specification regarding enablement and obviousness, despite Petitioner's arguments about the genus size.
Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.
Merck Sharp & Dohme LLC successfully challenged Halozyme, Inc.'s claims regarding modified PH20 polypeptides in a PTAB decision. The Board instituted trial based on enablement and written description grounds, finding that the broad genus of claimed molecules required undue experimentation to identify active variants.
Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.
Merck Sharp & Dohme LLC successfully petitioned the PTAB against Halozyme, Inc.'s '298 patent covering modified PH20 polypeptides. The Board granted institution despite challenges based on Written Description and Enablement, allowing the dispute to proceed to trial.
Intelligent Wellhead Systems, Inc. et al. v.Downing Wellhead Equipment, LLC et al.
The PTAB instituted PGR on claims 1-78 of the '952 patent after reviewing multiple grounds, including eligibility (§ 101), obviousness (§ 103), and written description/enablement (§ 112). The Board found a likelihood of success for Petitioner despite arguments from Patent Owner regarding prior art limitations.
Merck Sharp & Dohme LLC v.Halozyme, Inc. et al.
Merck Sharp & Dohme LLC successfully challenged Halozyme, Inc.'s patent on modified PH20 polypeptides in a PGR proceeding. The Board found likelihood of prevailing based on arguments regarding the genus's scope and potential lack of enablement/obviousness.
Catalyst OrthoScience Inc. v.Shoulder Innovations, Inc.
The PTAB denied Catalyst OrthoScience's Post-Grant Review of Shoulder Innovations' reverse shoulder implant patent (12,023,254). The denial was based on the advanced stage and significant overlap with co-pending district court litigation.
UATP IP, LLC et al. v.Slick Slide LLC
UATP IP successfully challenged the patentability of claims related to low-friction slide systems and mesh layers. The PTAB granted institution after finding likelihood of unpatentability, moving the case toward trial preparation while providing preliminary claim construction guidance on key terms.
Simpson Strong-Tie Company Inc. et al. v.Columbia Insurance Company et al.
The PTAB decided to institute PGR proceedings, finding that the Petitioner successfully overcame arguments of Examiner error regarding prior art combinations and claim construction issues. The dispute centers on fire-resistant wall assemblies and truss hangers, with the Board issuing preliminary determinations on key terms like 'planar extension plate' and 'bounding.'
Therabody, Inc. v.Hyperice IP Subco, LLC et al.
Therabody, Inc. successfully convinced the PTAB to institute proceedings against Hyperice IP Subco, LLC regarding a medical device patent (11857482). The Board found prima facie evidence of obviousness and indefiniteness across multiple claims based on prior art combinations.
Ecto World, LLC d/b/a Demand Vape et al. v.RAI Strategic Holdings, Inc. et al.
The PTAB denied the institution of a Post-Grant Review (PGR) petition challenging claims related to electrically-powered aerosol generators. The Board found that the petitioner failed to meet its burden of showing a likelihood of unpatentability, despite narrowing claim construction on 'smoking article' to devices containing tobacco.
PHISON ELECTRONICS CORPORATION v.Vervain, LLC
PHISON ELECTRONICS CORPORATION's petition challenging Vervain, LLC's NAND Flash Memory patent was denied by the PTAB. The Board found the specification sufficiently supported the claims against indefiniteness and written description challenges, and Petitioner failed to meet the likelihood standard for obviousness.
Phison Electronics Corporation v.Vervain, LLC.
The PTAB denied the petition challenging a NAND Flash Memory System patent based on grounds including 101, 112, and 103. The Board found that the claims were directed toward a technological improvement in memory storage and adequately supported by the specification.
Catalyst OrthoScience Inc. v.Shoulder Innovations, Inc.
Catalyst OrthoScience Inc.'s Post-Grant Review petition against Shoulder Innovations, Inc. was denied by the PTAB. The Board found that Petitioner failed to establish a 'compelling merits' showing for either obviousness (103) or indefiniteness (112).
3D Diagnostix, Inc. v.Watson Guide IP, LLC
3D Diagnostix successfully petitioned to institute IPR against Watson Guide IP regarding dental prosthesis claims under 103. The Board found sufficient evidence of obviousness, despite disputes over claim language and prior art interpretation.
Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.
Samsung Electronics successfully petitioned to challenge Ouraring's patent (11874702) in a PGR proceeding, leading the PTAB to grant institution. The Board determined that the challenges based on prior art met the institutional threshold for trial.
MPL Brands NV, Inc. v.BuzzBallz, LLC
MPL Brands NV successfully petitioned for institution of its obviousness challenge against BuzzBallz's beverage container patent (11932441). The Board found that the design application introduced new matter, making the claims eligible for review.
Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.
The PTAB denied a Post-Grant Review filed by Samsung against Oura Health's patent '701 because the Patent Owner had disclaimed all challenged claims.
BESTWAY (USA), INC. et al. v.Intex Marketing Ltd. et al.
Bestway challenged Intex's patent, but the PTAB denied institution because Intex had statutorily disclaimed all claims. The Board also declined to enter an adverse judgment against Intex.
Good Sportsman Marketing, LLC v.--
Good Sportsman Marketing challenged Hangzhou ZH Tech's patent (11736855) in PGR, alleging obviousness and indefiniteness across 19 claims. The Board instituted the petition, finding a likelihood that at least one claim is unpatentable based on prior art combinations.
Front Line Medical Technologies Inc. v.Prytime Medical Devices, Inc.
The PTAB institution decision found that the petitioner successfully demonstrated a likelihood of prevailing on its obviousness challenges against all ten claims. The Board adopted broad claim constructions for 'proximal hub' and 'flow valve,' finding they could be separate or sub-elements, which supported the grounds of obviousness over various prior art combinations.
Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.
The PTAB denied Samsung's Post-Grant Review petition against Ouraing because the patent owner had statutorily disclaimed all 16 challenged claims.
Samsung Electronics Co., Ltd. et al. v.Oura Health Oy et al.
Samsung Electronics successfully petitioned to challenge Oura Health's patent (11868178) in a PGR proceeding, leading the PTAB to institute the case. The Board found Petitioner's arguments regarding prior art disclosures for battery and PCB placement sufficient to proceed to trial.
Godbersen-Smith Construction Company d/b/a GOMACO Corporation v.Guntert & Zimmerman Const. Div., Inc.
GOMACO Corporation successfully challenged seven claims of the '723 patent in a PGR proceeding, arguing they lack written description support and are obvious. The Board instituted review on all grounds, finding the patent subject to AIA rules despite its age.
Inari Agriculture, Inc. v.Pioneer Hi-Bred International, Inc.
The PTAB denied Inari Agriculture's PGR challenge against Pioneer Hi-Bred International regarding maize breeding claims (1-20). The Board found the petitioner failed to demonstrate unpatentability on grounds of obviousness, utility, or indefiniteness.
Inari Agriculture, Inc. v.Pioneer Hi-Bred International, Inc.
The PTAB denied institution of Inari Agriculture's PGR against Pioneer Hi-Bred International regarding maize breeding claims. The Board found the Petitioner failed to demonstrate a reasonable expectation of success, specifically failing to adequately address the unique genotype (PH4CYJ) central to the patent.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.